Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

66 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Interactions of ofloxacin and erythromycin with the multidrug resistance protein (MRP) in MRP-overexpressing human leukemia cells.
Terashi K, Oka M, Soda H, Fukuda M, Kawabata S, Nakatomi K, Shiozawa K, Nakamura T, Tsukamoto K, Noguchi Y, Suenaga M, Tei C, Kohno S. Terashi K, et al. Among authors: nakatomi k. Antimicrob Agents Chemother. 2000 Jun;44(6):1697-700. doi: 10.1128/AAC.44.6.1697-1700.2000. Antimicrob Agents Chemother. 2000. PMID: 10817732 Free PMC article.
Breast cancer resistance protein directly confers SN-38 resistance of lung cancer cells.
Kawabata S, Oka M, Shiozawa K, Tsukamoto K, Nakatomi K, Soda H, Fukuda M, Ikegami Y, Sugahara K, Yamada Y, Kamihira S, Doyle LA, Ross DD, Kohno S. Kawabata S, et al. Among authors: nakatomi k. Biochem Biophys Res Commun. 2001 Feb 9;280(5):1216-23. doi: 10.1006/bbrc.2001.4267. Biochem Biophys Res Commun. 2001. PMID: 11162657
Autoantibody to heat shock protein Hsp40 in sera of lung cancer patients.
Oka M, Sato S, Soda H, Fukuda M, Kawabata S, Nakatomi K, Shiozawa K, Nakamura Y, Ohtsuka K, Kohno S. Oka M, et al. Among authors: nakatomi k. Jpn J Cancer Res. 2001 Mar;92(3):316-20. doi: 10.1111/j.1349-7006.2001.tb01097.x. Jpn J Cancer Res. 2001. PMID: 11267942 Free PMC article.
Phase I study of irinotecan and cisplatin with concurrent split-course radiotherapy in limited-disease small-cell lung cancer.
Oka M, Fukuda M, Kuba M, Ichiki M, Rikimaru T, Soda H, Tsurutani J, Nakamura Y, Kawabata S, Nakatomi K, Narasaki F, Nagashima S, Takatani H, Fukuda M, Kinoshita A, Kohno S. Oka M, et al. Among authors: nakatomi k. Eur J Cancer. 2002 Oct;38(15):1998-2004. doi: 10.1016/s0959-8049(02)00191-0. Eur J Cancer. 2002. PMID: 12376204 Clinical Trial.
66 results